Functional Antibody Responses to GEN-003, a Herpes Simplex Virus Immunotherapy that Durably Reduces Viral Shedding up to 12 Months Post Dosing

Authors :: Thomas Oliphant
Jessica Flechtner
Amy Baccari
Johanna K. Kaufmann
Seth Hetherington
Bin Zhang
Nicolle Siddall
Lisa K. McNeil
Shane Larson
Veronica Clemens
Source :: Open Forum Infectious Diseases. 3
Publication Year :: 2016
Publisher :: Oxford University Press (OUP), 2016.

Subjects :: Infectious Diseases
Herpes simplex virus
Antibody response
Oncology
business.industry
medicine.medical_treatment
medicine
Immunotherapy
Dosing
Viral shedding
medicine.disease_cause
business
Virology

Full Text Access

Tools